SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes

Patients with type 2 diabetes treated with SGLT2 inhibitors vs other common diabetes drugs show up to a 31% reduced risk of kidney stone development.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news